Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA harmonization

Executive Summary

Agency has the draft report of the task force on harmonization and is "working to see how to best meld the activities that are suggested in that with FDA's own long-term planning document," Associate Commissioner for Health Affairs Stuart Nightingale tells the Parenteral Drug Association/FDA 1992 Joint Conference on Sept. 21. The report will help FDA set priorities and allocate resources for its harmonization activities, he notes. The agency hopes the report will be publicly available "soon".

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021520

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel